← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Introgen Therapeutics, Inc.
Houston, TX
$2,847,442
Total funding
6
Grants
Funding mix
By agency
NIH$2,847,442 · 6
By mechanism
R42$1,546,693 · 1
R41$874,971 · 3
R43$425,778 · 2
Investigators at Introgen Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Gene Therapy for Human Malignant Melanoma$606,567
R42 · FY2004 · CA
Gene Therapy for Human Malignant Melanoma$598,308
R42 · FY2005 · CA
Gene Therapy for Human Malignant Melanoma$341,818
R42 · FY2003 · CA
GENE THERAPY FOR HUMAN MALIGNANT MELANOMA$247,353
R41 · FY2001 · CA
GENE THERAPY FOR HUMAN MALIGNANT MELANOMA$245,250
R41 · FY2002 · CA
NOVEL GENE THERAPEUTIC FOR THE TREATMENT OF LUNG CANCER$238,528
R43 · FY2000 · CA
RADIOSENSITIZATION BY ANTIRAS SCFV-EXPRESSING ADENOVIRUS$207,445
R41 · FY2000 · CA
Ad-mda7 plus Herceptin against Breast Cancer$187,250
R43 · FY2002 · CA
TUMOR CELL RADIOSENSITIZATION BY ADENOVIRAL-MEDIATED P16$174,923
R41 · FY2000 · CA